AMEX:AEON (USA)
Â
Ordinary Shares - Class A
$
0.98
+0.01705 (+1.78%)
11:09 PM EST
Business Description
AEON Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US00791X1000
Share Class Description:
AEON: Ordinary Shares - Class ADescription
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.29 | |||||
Equity-to-Asset | -65.43 | |||||
Debt-to-Equity | -0.03 | |||||
Debt-to-EBITDA | -0.51 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | 33.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.54 | |||||
9-Day RSI | 30.6 | |||||
14-Day RSI | 31.32 | |||||
6-1 Month Momentum % | -77.98 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.16 | |||||
Quick Ratio | 0.16 | |||||
Cash Ratio | 0.1 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -35.9 | |||||
Shareholder Yield % | 339.69 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -1287.66 | |||||
ROIC % | -360.08 | |||||
ROC (Joel Greenblatt) % | -1751.57 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -4.04 | |||||
EV-to-Forward-EBIT | -3.26 | |||||
EV-to-EBITDA | -4.05 | |||||
EV-to-FCF | -4.88 | |||||
Earnings Yield (Greenblatt) % | -24.75 | |||||
FCF Yield % | -22.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:AEON
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AEON Biopharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -3.17 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 31.32 | ||
14-Day ATR ($) | 0.191147 | ||
20-Day SMA ($) | 1.249908 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0.9176 - 17.17 | ||
Shares Outstanding (Mil) | 39.12 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AEON Biopharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AEON Biopharma Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
AEON Biopharma Inc Frequently Asked Questions
What is AEON Biopharma Inc(AEON)'s stock price today?
The current price of AEON is $0.98. The 52 week high of AEON is $17.17 and 52 week low is $0.92.
When is next earnings date of AEON Biopharma Inc(AEON)?
The next earnings date of AEON Biopharma Inc(AEON) is 2024-08-30 Est..
Does AEON Biopharma Inc(AEON) pay dividends? If so, how much?
AEON Biopharma Inc(AEON) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |